Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So am I ..
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Dowling Joseph D
(Last) (First) (Middle)
10070 BARNES CANYON ROAD
(Street)
SAN DIEGO CA 92121
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CV Sciences, Inc. [ CVSI ] 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $ 4.72 02/20/2019 A 500,000 (1) 02/19/2029 Common Stock 500,000.00 $ 0 500,000 D
Explanation of Responses:
1. The option is durational-based. 250,000 option shares vested on the date of grant and the remaining 250,000 option shares vest and become exercisable on May 20, 2019, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service.
/s/ Joerg Grasser as Attorney-in-fact for Joseph D. Dowling 03/19/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
I agree with you on that !
Hang in there ,buy more i am, LOOK what is going on around .This will be 6.00 again in 2021 you !!!!!!!!
That's what I thought it was !
You know what we are all going to find out next Monday !!!!!!!!!!
I agree with you on that !
I will say 14 mill. as my guess
Yes it is a bad day in the market today , But I got more CVSI shares at .59 . Time to buy and I hope we at least meet the earnings report tomorrow ! either way good or bad I am CVSI LONG !!!!!!!!!!!
I sure do hope i am wrong , That is for sure...
I think this is the high, and you may want to sell on the open Monday Morning !
I already know what is going to happen here ,The shorts are pumping this up and then short it down to abut .58 a share or so . They do this every dam Friday . mark my word it is going to happen . JUST WATCH IT IS FRIDAY SAME O SAME O
I already know what is going to happen here ,The shorts are pumping this up and then short it down to abut .58 a share or so . They do this every dam Friday . mark my word it is going to happen . JUST WATCH
I really do not think you can go wrong loading up now or later . We all know what this company is about , It will come back and when it does it will be with a-vengeance !! That is my opinion so load up now !
same here .lol
Charlottes Web (QX) Stock Price - CWBHF
2
Follow CWBHF
4.8274
-0.1726 (-3.50%) Upgrade to Real-Time
Market Open
Company Name Stock Ticker Symbol Market Type
Charlottes Web Holdings Inc (QX) CWBHF OTCMarkets Common Stock
Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.1726 -3.5% 4.8274 4.62 4.98 4.98 5.00 10:45:04
Bid Price Ask Price Spread Spread % News
4.80 4.84 0.04 0.8% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
980 310,532 $ 4.7821 $ 1,484,981 533,530 4.62 - 25.25
Last Trade Time Type Quantity Stock Price Currency
10:45:04 900 4.8274 USD
Me
You only speak the truth ! And you are welcome ..
CWBHF
ecurity Type: Common Stock
Bid 5.00
Bid Size 0
Ask 5.02
Ask Size 0
Open 5.20
Day High 5.38
Day Low 4.74
Previous Close 5.00
52-Week High 25.25
04/04/2019
52-Week Low 4.74
02/27/2020
Price Performance (Last 52 Weeks) -66.16%
Held by ETPs
No
Volume 893,431
90-Day Average Volume 548,566
Primary Exchange OTC Markets
Index Not In
S&P 500®
DJIA®
NASDAQ 100®
Options
No
Detailed Quote
Same here .
I think your thinking the same thing as me ! 6.8 million in revs. We shell see !
or a little HOPE !
Sorry , but I only posted what little i could find to try and give everyone heads up.
Consumers Clamor for CBD as More Novel Uses are Purported
BY PR Newswire
— 9:00 AM ET 02/11/2020
NEW YORK, Feb. 11, 2020 /PRNewswire/ -- Earlier in 2018, the Farm Bill restored industrial hemp to nationwide legal production for the first time since World War II. Removing hemp from the Controlled Substances Act of 1970 (CSA) also helped create a financial domino effect – eventually leading to mass-market retailers CVS Health, Rite Aid, and Walgreens Boots Alliance to carry hemp-CBD brands. Notably, cannabis-based oils have become widely popular because of their potent and immediate effects. In fact, CBD products overall are having a major impact on the global industry because they offer a number of therapeutic benefits without the psychoactive effects of THC. Currently, this segment of the cannabis industry is also gaining prevalence for its potential to treat serious medical conditions such as cancer, multiple sclerosis, Alzheimer's, Parkinson's, depression, and anxiety. And as the U.S. hemp industry matures, it is expected to transition from being a seed, textile, and industrial product importer to a global exporter. And according to data compiled by Hemp Business Journal, a division of New Frontier Data, the total sales for the U.S. hemp industry totaled USD 820 Million in 2017. The research also suggests that the industry is expected to grow to USD 1.9 Billion by 2022 and at a CAGR of 14.4% during the 5-year period. U.S. Lithium Corp. ( LITH
Loading...
Loading...
) , Aphria Inc. , CV Sciences ( CVSI
Loading...
Loading...
), Inc (OTC: CVSI), CannTrust Holdings Inc. , HEXO Corp. ( HEXO
Loading...
Loading...
)
The 2018 Farm Bill, however, explicitly preserved the FDA's authority to regulate products containing cannabis or cannabis-derived compounds under the FD&C Act and section 351 of the Public Health Service Act (PHS Act). This leaves a lot of uncertainties regarding which products can be sold legally. According to the FDA, it treats products containing cannabis or cannabis-derived compounds as it does any other FDA-regulated products - meaning they're subject to the same authorities and requirements as FDA-regulated products containing any other substance. This is true regardless of whether the cannabis or cannabis-derived compounds are classified as hemp under the 2018 Farm Bill. And despite the federal regulatory uncertainties, at least 70% of the 2019 U.S. hemp harvest is intended for extract production, with Colorado leading the nation in hemp cultivation and processing land area with over 80,000 acres reported. "The 29 U.S. states reporting licensed hemp cultivation acreage total almost half a million acres in combined cultivation land area, which is a massive increase compared to 2018 figures of a total land area barely over 100,000 acres. While there continues to be uncertainty and a healthy amount of confusion around hemp cultivation for CBD production, it is clear that demand is nonetheless continuing to rise across the U.S.," noted Giadha Aguirre de Carcer, New Frontier Data CEO and Founder. "As states issue more licenses, consumer demand increases, and mass-market retailers such as CVS and Walgreens continue to expand their own product offerings, we expect the FDA may be forced to provide further regulatory clarifications sooner rather than later."
U.S. Lithium Corp. ( LITH
Loading...
Loading...
) (OTC: LITH) announced earlier last week that, "its Board of Directors and shareholders have approved an amendment to the Articles of Incorporation changing the name of the corporation from U.S. Lithium Corp. ( LITH
Loading...
Loading...
) to BioELife Corp. The name change will better reflect the Company's new strategic focus on the rapidly growing CBD market. The Company expects this action will become effective within the next 30 days. The Company will also be launching a new website and seek a new trading symbol for its common stock immediately after the name change becomes effective.
'BioELife reflects the Company's new direction into helping improve individual lives through non-addictive remedies for stress and pain relief as well as other medical purposes,' stated Gregory Rotelli, Chairman of the Board and President of LITH. Mr. Rotelli further stated, 'We're positioning our Company as 'Nature's Bio Equivalent' with a 'seed to shelf' philosophy. Our raw materials are sourced directly from our partner farms in America's heartland which grow only the best quality CBD strains for use in all our formulations. Throughout our farming and GMP manufacturing process, our products are made using the purest and most potent ingredients available and are backed by clinical data and independent laboratory testing.'
BioELife currently partners with well-known farmers, certified contract manufacturers and key distributors to produce and distribute exceptional products at the lowest possible cost. Positive testimonials from BioELife clients and patients continue to substantiate the Company's objective to provide products that perform better than any currently on the market and often better than prescription medications. The Company has already expanded manufacturing and distribution channels in these first few weeks since entering the CBD industry.
About the Company: US Lithium Corp's new strategic direction as BioELife was created by successful pharmaceutical entrepreneurs dedicated to using nature's resources to fight pain and infection while reducing the dependency on opioids and their terrible side effects. The Company is uniquely positioned to capitalize on the emerging Cannabinoid market that is growing at phenomenal rates and is expected to reach $20 Billion over the next five years. The Company has created a 'seed to shelf' value-added product development and marketing organization with direct contracts for raw materials, scientific formulation, manufacturing, and distribution of medically focused Cannabinoid products. In order to better reflect this new strategic direction, the Company is in the process of changing its name and symbol to BioELife which should be effective within the next thirty days."
For our latest "Buzz on the Street" Show featuring U.S. Lithium Corp. ( LITH
Loading...
Loading...
) recent corporate news, please head over to: https://www.youtube.com/watch?v=Fh5N0DqJSts
Aphria Inc. ( APHA
Loading...
Loading...
) through its subsidiary Aphria Deutschland GmbH announced last april, the launch of the Company's first CBD-based nutraceutical, the first product in its CBD-based cosmetics line for the German market. Featuring CBD derived from hemp, the CannRelief brand of products are being produced in the European Union and distributed by the Company's subsidiary, CC Pharma, which has access to more than 13,000 pharmacies throughout Germany. "We are excited to introduce our first brand of CBD products for the German nutraceutical and cosmetics market," said Jakob Ripshtein, President of Aphria ( APHA
Loading...
Loading...
). "Supported by our extensive distribution network through CC Pharma, CannRelief provides a natural extension to Aphria's ( APHA
Loading...
Loading...
) growing business opportunities in the German medical cannabis market. We look forward to providing a full range of CannRelief CBD products this year."
CV Sciences, Inc ( CVSI
Loading...
Loading...
) , a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its brand PlusCBD Oil™, announced that it is the first-ever CBD sponsor of the Farmers Insurance Open. The Farmers Insurance Open is a PGA Golf tournament that took place Thursday, Jan. 23, through Sunday, Jan. 26, at Torrey Pines Golf Course in San Diego, California. "We are proud to be the official CBD Partner of the Farmers Insurance Open as this serves as another proof point of our commitment to safe, high-quality products," said Joseph Dowling, Chief Executive Officer, CV Sciences. "We believe both professional and amateur golfers can benefit from PlusCBD™ Oil products and we look forward to increasing our visibility among the golf community through this sponsorship."
CannTrust Holdings Inc. is a federally regulated licensed producer of medical and recreational cannabis in Canada, and the 2018 Canadian Cannabis Awards "Top Licensed Producer of the Year". CannTrust Holdings Inc. recently announced it has finalized a Letter of Intent with Société québécoise du cannabis to provide Quebec with high-quality cannabis for the recreational market. The LOI will serve as an introduction of CannTrust's recreational brands to the Quebec market beginning with two of the Company's most established strains that will be available through SQDC later this year. "This LOI signifies the first step towards a long and impactful relationship with the SQDC and consumers in Quebec. This is an important milestone as we have secured national distribution across all ten provinces for our adult-use products," said Peter Aceto, Chief Executive Officer, CannTrust. "This will allow us to develop our brand presence in Quebec at a time when consumers are beginning to develop their preferences."
HEXO Corp. ( HEXO
Loading...
Loading...
) is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. HEXO Corp. ( HEXO
Loading...
Loading...
) recently announced that it had received licenses from Health Canada for its cannabis Centre of Excellence in Belleville, Ontario, for research, and for the sale of cannabis topicals, extracts, edibles and beverages from its flagship Gatineau campus. While a Processing Licence provides for testing on live plants, fresh and dried plant material, seeds, and oil, a Research and Development Licence significantly expands the scope of work that can be conducted on cannabis and its derivatives. The Company plans to conduct research and development at its Vaughan and Montreal Innovation, Development and Engineering hubs, as well as at its Centre of Excellence in Belleville and in other facilities. "The research licence will allow us to take our innovation work to the next level, with testing on derivative products, including taste testing. Consumers have high expectations for their packaged goods experiences, and cannabis will be no different," said Sebastien St-Louis, Chief Executive Officer and Co-Founder of HEXO Corp. ( HEXO
Loading...
Loading...
) "We are committed to not only ensuring a quality consistent experience but to also guaranteeing that experiences powered by HEXO ( HEXO
Loading...
Loading...
) meet these expectations."
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Please NoteFinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. FinancialBuzz.com has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, FinancialBuzz.com has not been compensated for financial news dissemination and PR services by any parties. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.FinancialBuzz.com.
Mine to !!! Chill needs to go Chill
Looks like it !
I sure hope the FDA gets off their ass ! Hemp CBD Is a Bust. Farmers Are Disappointed. -- Barrons.com
BY Dow Jones & Company, Inc.
— 10:00 AM ET 01/31/2020
Many farmers planted hemp last year, hoping for a bit of the billions in sales predicted for the newly legal, nonintoxicating variety of cannabis that yields the soothing stuff called CBD. But demand didn't materialize, so piles of hemp "biomass" sit unsold, and the price of what does sell fell about 30% from December to January, according to researchers at New Leaf Data Services.
It's a glut and it is going to get worse. "[L]arge volumes of biomass remain unsold," says New Leaf's Hemp Benchmarks report for January, "suggesting that further price erosion is possible."
Demand for CBD, or cannabidiol, extracted from the biomass is equally poor. Inventories are growing and cash transactions are rare. When sales of CBD oil did occur, says the report, the price in January was 25% below December's.
Even Republican Sen. Mitch McConnell was a hemp enthusiast when Congress legalized the plant in late 2018, hoping for a new cash crop to make up for declining sales of tobacco in states like McConnell's Kentucky. Cowen & Co. analysts predicted that CBD would prove a $16 billion opportunity for companies like Canopy Growth ( CGC
Loading...
Loading...
) and Tilray ( TLRY
Loading...
Loading...
) . Boosters believed that CBD products would soon line the food, beverage and cosmetics aisles of supermarkets, drugstores, and mass merchandisers. Fashionable people would wear hemp threads. Barron's was skeptical.
See our April CBD feature: CBD Is the New Marijuana. But Don't Buy Into the Craze for Hemp Stocks .
Consumer packaged-goods giants like PepsiCo (PEP) and big retailers like Walmart (WMT) haven't committed to CBD- laced products. A big reason for that is concerns voiced by the U.S. Food and Drug Administration, which says it can't permit the biologically-active ingredient in food and drink without tests of CBD's safety. State health regulators in places such as California are also keeping it off shelves.
Even mail-order specialists like Charlotte's Web Holdings ( CWBHF
Loading...
Loading...
) (CWEB. Canada) blame regulators for stunting CBD's sales growth. The company's stock has slid 60% since our April article, while those of CBD plays CV Sciences ( CVSI
Loading...
Loading...
) and Green Growth Brands (GGB. Canada) are down more than 80%.
CBD may someday become a hot health additive, but for now, farmers are pulling back. Hemp Benchmarks reports that only a fraction of the acreage licensed to grow hemp was harvested in 2019, yet a glut still resulted.
As the 2020 planting season approaches, farmers ought to be buying seeds and starter plants. But in a time of year when demand for those things should be high, the market researchers are finding that their January prices are lower than they were in October.
"Wholesale hemp markets continue to face significant challenges," says Hemp Benchmarks.
Write to Bill Alpert at william.alpert@barrons.com
Market is closed Monday !
I did not think this small run would hold , people are taking some profits. It always happens every time on Fridays . I hope it hold but think it will go down to 1.15 share by end of day !.
Anyone know when the next ER is ?
Happy New Year to all !!
Merry Christmas to all !
I got 5 ad emails from cvsi today, looks like they are getting them out
Looks more like $3.00 is coming to me !!!!!!!!!!
I think this is old news !!
My guess is that CVSI will drop to about 1.25 a share since this is Friday and a lot of stock holders will take some profit off the table to try and make a buck ! CVSI LONG
You hit this right on the Head ! back where we open at .
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 15, 2019, Michael Mona III submitted his resignation from his position as CV Sciences, Inc.'s Chief Operating Officer ("COO"), effective January 1, 2020.